Trials / Terminated
TerminatedNCT00574756
Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
The Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of California, San Diego · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ranolazine | extended release 500 mg twice a day for two weeks |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2007-12-17
- Last updated
- 2019-08-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00574756. Inclusion in this directory is not an endorsement.